MedTrace Logo

Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding

NCT04878614 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2023-04-10

No results posted yet for this study

Summary

The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience.

Conditions

Interventions

DRUG

Levothyroxine Tablet

Standard clinical management

DRUG

Levothyroxine Sodium

Liquid levothyroxine through enteral feeding tube

Sponsors & Collaborators

Principal Investigators

  • Vijiya Surampudi, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-02-16
Completion
2022-02-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878614 on ClinicalTrials.gov